John A Fornadley1. 1. Clinical Associate Professor of Surgery, Division of Otolaryngology Penn State University, Hershey, PA.
Abstract
BACKGROUND: Allergy is diagnosed by a combination of history, physical examination, and confirmatory testing. Modalities for testing include skin testing, in vitro assessment, and challenge testing of the conjunctiva or nasal mucosa. Challenge testing is primarily reserved for research. METHODS: A review of the literature on skin testing methods for inhalant allergic rhinitis was performed. RESULTS: Different forms of commonly used skin testing are available, including: individual prick; multiple prick; single, intradermal, and intradermal dilutional testing; and blended techniques. Each has inherent benefits and limitations. CONCLUSION: Skin testing remains a valid and in some cases superior means of identifying inhalant allergy. Skin-prick testing and intradermal testing are the primary categories, although different formats exist for each. Caution must be taken to avoid creating a serious systemic reaction by injecting an injudicious amount of antigen into the skin, or in skin testing a patient whose medication profile puts them at increased risk.
BACKGROUND:Allergy is diagnosed by a combination of history, physical examination, and confirmatory testing. Modalities for testing include skin testing, in vitro assessment, and challenge testing of the conjunctiva or nasal mucosa. Challenge testing is primarily reserved for research. METHODS: A review of the literature on skin testing methods for inhalant allergic rhinitis was performed. RESULTS: Different forms of commonly used skin testing are available, including: individual prick; multiple prick; single, intradermal, and intradermal dilutional testing; and blended techniques. Each has inherent benefits and limitations. CONCLUSION: Skin testing remains a valid and in some cases superior means of identifying inhalant allergy. Skin-prick testing and intradermal testing are the primary categories, although different formats exist for each. Caution must be taken to avoid creating a serious systemic reaction by injecting an injudicious amount of antigen into the skin, or in skin testing a patient whose medication profile puts them at increased risk.
Authors: Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek Journal: Int Forum Allergy Rhinol Date: 2018-02 Impact factor: 3.858
Authors: Tesfaye B Mersha; Yashira Afanador; Elisabet Johansson; Steven P Proper; Jonathan A Bernstein; Marc E Rothenberg; Gurjit K Khurana Hershey Journal: Clin Rev Allergy Immunol Date: 2021-04 Impact factor: 8.667